- Home
- MDGL vs UHS Comparison
MDGL vs UHS Comparison
Compare MDGL & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | UHS |
|---|---|---|
| Founded | 2011 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 13.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDGL | UHS |
|---|---|---|
| Price | $588.97 | $216.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | ★ $580.77 | $232.58 |
| AVG Volume (30 Days) | 268.0K | ★ 683.9K |
| Earning Date | 11-04-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 0.37% |
| EPS Growth | N/A | ★ 39.76 |
| EPS | N/A | ★ 21.01 |
| Revenue | $740,640,000.00 | ★ $16,992,503,000.00 |
| Revenue This Year | $435.63 | $10.92 |
| Revenue Next Year | $52.56 | $5.00 |
| P/E Ratio | ★ N/A | $10.38 |
| Revenue Growth | ★ 864.21 | 10.21 |
| 52 Week Low | $265.00 | $152.33 |
| 52 Week High | $615.00 | $246.33 |
Technical Indicators
Market Signals| Indicator | MDGL | UHS |
|---|---|---|
| Relative Strength Index (RSI) | 58.31 | 36.30 |
| Support Level | $578.00 | $223.44 |
| Resistance Level | $615.00 | $229.15 |
| Average True Range (ATR) | 17.87 | 3.97 |
| MACD | -1.99 | -1.07 |
| Stochastic Oscillator | 65.70 | 21.00 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.